Recruiting soon

SPORT-MUResistance Training Program for Prostate Cancer Patients on Androgen Deprivation Therapy

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Exercise Intervention Protocol

+ SPoRT-Control Intervention

Procedure
Who is being recruted

Urogenital Diseases+7

+ Genital Diseases

+ Genital Diseases, Male

Over 18 Years
+7 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: November 2025
See protocol details

Summary

Principal SponsorFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Study ContactEnrique Cao Avellaneda, MDMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: November 15, 2025

Actual date on which the first participant was enrolled.

This study is exploring the impact of a structured exercise program on men with prostate cancer who are undergoing a common treatment called androgen deprivation therapy (ADT). Prostate cancer patients often experience side effects from ADT that affect their physical and mental well-being. This research aims to find out if a 24-week exercise program can help improve these patients' physical strength, daily functioning, and overall mood. By comparing two different types of exercise routines, the study hopes to discover which one is more beneficial, potentially leading to better care and quality of life for these patients. Participants in this study are randomly assigned to one of two groups. One group follows a supervised resistance training program, while the other does exercises at home with guidance given during the first session and regular phone check-ins. Evaluations occur at the start, halfway through, and at the end of the 24 weeks to see how the exercise affects physical, functional, and emotional health. This setup allows researchers to measure both the immediate and lasting effects of the exercise programs, offering insights into which approach might be more effective for men undergoing ADT.

Official TitleStandardized Resistance Training Program and Assessment System for Prostate Cancer Patients Receiving Androgen Deprivation Therapy ISPoRT-PCa-ADT Study Protocol for a Randomized Controlled Trial. SPORT-MU
NCT07064811
Principal SponsorFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Study ContactEnrique Cao Avellaneda, MDMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

60 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Male

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesGenital DiseasesGenital Diseases, MaleGenital Neoplasms, MaleNeoplasmsNeoplasms by SiteProstatic DiseasesProstatic NeoplasmsUrogenital NeoplasmsMale Urogenital Diseases

Criteria

3 inclusion criteria required to participate
diagnosis of locally advanced or metastatic prostate neoplasm and current treatment with androgen deprivation therapy (ADT)

treatment at the radiotherapy oncology department of University Clinical Hospital "Virgen de la Arrixaca"

legal adult age with signed informed consent

4 exclusion criteria prevent from participating
unwillingness to participate in the study

inability to complete adequate follow-up due to any cause that would prevent knowledge of patient evolution during the follow-up period

no controlled or symptomatic metastatic bone disease

physical disabilities that would prevent participants from safely completing the exercise protocol

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
24-week home based resistance training program .

Group II

Experimental
24 week velocity based resistance training. Twice weekly supervised sessions

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

HCUVA

Murcia, SpainOpen HCUVA in Google Maps
Recruiting soonOne Study Center